Burlington Medical, LLC recalls Burlington Medical, Frontal Aprons
- Recall date
- February 11, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1756-2026
- FDA classification
- Class II
- Brand / firm
- Burlington Medical, LLC
- Sold / distributed
- Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.
Why it was recalled
Potential for attenuation degradation over time, decreasing the lifespan.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Burlington Medical, Frontal Aprons
Get recall alerts
Free email alert whenever Burlington Medical, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Burlington Medical, LLC